Ironwood Pharmaceuticals, Inc.
IRWD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $140 | $93 | $108 | $89 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $120 | $86 | $40 | $82 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $13 | $13 | $12 | $12 |
| Total Curr. Assets | $274 | $192 | $161 | $182 |
| Property Plant & Equip (Net) | $13 | $14 | $15 | $16 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $2 | $2 | $3 | $3 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $102 | $129 | $144 | $144 |
| Other NC Assets | $5 | $5 | $6 | $6 |
| Total NC Assets | $122 | $151 | $167 | $169 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $396 | $343 | $327 | $351 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $6 | $2 |
| Short-Term Debt | $200 | $199 | $3 | $0 |
| Tax Payable | $0 | $1 | $0 | $1 |
| Deferred Revenue | $1 | $1 | $2 | $2 |
| Other Curr. Liab. | $17 | $13 | $31 | $5 |
| Total Curr. Liab. | $243 | $233 | $48 | $39 |
| LT Debt | $385 | $385 | $584 | $584 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $22 | $22 | $17 | $17 |
| Total NC Liab. | $418 | $419 | $613 | $613 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $14 | $14 | $0 | $15 |
| Total Liabilities | $660 | $651 | $661 | $652 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,671 | -$1,712 | -$1,735 | -$1,698 |
| AOCI | -$2 | -$2 | $0 | $1 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$264 | -$308 | -$334 | -$301 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $396 | $343 | $327 | $351 |
| Net Debt | $444 | $491 | $479 | $495 |